{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:17:31Z","timestamp":1795223851939,"version":"4.10.3"},"reference-count":21,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Mild traumatic brain injury (mTBI) is a major cause of emergency room (ER) admission. Thirty percent of mTBI patients have postconcussion syndrome (PCS), and 15% have symptoms for over a year. This population is underdiagnosed and does not receive appropriate care. The authors proposed a fast and inexpensive fluorometric measurement of circulating cell-free DNA (cfDNA) as a biomarker for PCS. cfDNA is a proven, useful marker of a variety of acute pathological conditions such as trauma and acute illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Thirty mTBI patients were recruited for this prospective single-center trial. At admission, patients completed questionnaires and blood was drawn to obtain cfDNA. At 3\u20134 months after injury, 18 patients returned for cognitive assessments with questionnaires and the Color Trails Test (CTT). The fast SYBR Gold assay was used to measure cfDNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Seventeen men and 13 women participated in this trial. The mean \u00b1 SD age was 50.9 \u00b1 13.9 years. Of the 18 patients who returned for cognitive assessment, one-third reported working fewer hours, 4 (22.2%) changed their driving patterns, and 5 (27.7%) reduced or stopped performing physical activity. The median cfDNA level of the mTBI group was greater than that of the matched healthy control group (730.5 vs 521.5 ng\/ml, p = 0.0395). Admission cfDNA concentration was negatively correlated with performance on the CTT1 and CTT2 standardized tests (r = \u22120.559 and \u22120.599), meaning that greater cfDNA level was correlated with decreased cognitive performance status. The performance of the patients with normal cfDNA level included in the mTBI group was similar to that of the healthy participants. In contrast, the increased cfDNA group (&gt; 800 ng\/ml) had lower scores on the CTT tests than the normal cfDNA group (p &lt; 0.001). Furthermore, patients with moderate\/severe cognitive impairment according to CTT1 results had a greater median cfDNA level than the patients with scores indicating mild impairment or normal function (1186 vs 473.5 ng\/ml, p\n                      <jats:italic>=<\/jats:italic>\n                      0.0441, area under the receiver operating characteristic curve = 0.8393).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The data from this pilot study show the potential to use cfDNA, as measured with a fast test, as a biomarker to screen for PCS in the ER. A large-scale study is required to establish the value of cfDNA as an early predictor of PCS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2021.5.jns21501","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T04:05:30Z","timestamp":1634875530000},"page":"1660-1666","source":"Crossref","is-referenced-by-count":1,"title":["Quick cell-free DNA testing for the prediction of postconcussion syndrome: a single-center prospective pilot trial"],"prefix":"10.3171","volume":"136","author":[{"given":"Ido","family":"Ben Zvi","sequence":"first","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren Shaia","family":"Harel","sequence":"additional","affiliation":[{"name":"Occupational Therapy Department, School of Health Professions, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Douvdevani","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and Pharmacology, Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penina","family":"Weiss","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cohen","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eynat","family":"Ben Ari","sequence":"additional","affiliation":[{"name":"Occupational Therapy Department, School of Health Professions, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehonatan","family":"Menndel","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Felzensztein","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drescher","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagi","family":"Harnof","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Rabin Medical Center, Petah Tikva, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"5","key":"b1","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(15)00002-2","article-title":"Diagnosis, prognosis, and clinical management of mild traumatic brain injury","volume":"14","author":"Levin HS","year":"2015","unstructured":"Levin HS, Diaz-Arrastia RR. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol. 2015;14(5):506\u2013517.2580154710.1016\/S1474-4422(15)00002-2"},{"issue":"9","key":"b2","series-title":"Brain Inj","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/02699052.2017.1357836","article-title":"Biofluid biomarkers of traumatic brain injury","volume":"31","author":"Agoston DV","year":"2017","unstructured":"Agoston DV, Shutes-David A, Peskind ER. Biofluid biomarkers of traumatic brain injury. Brain Inj. 2017;31(9):1195\u20131203.2898134110.1080\/02699052.2017.1357836"},{"issue":"4","key":"b3","series-title":"Nat Rev Neurol","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","article-title":"Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood","volume":"9","author":"Zetterberg H","year":"2013","unstructured":"Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013;9(4):201\u2013210.2339964610.1038\/nrneurol.2013.9"},{"issue":"6","key":"b4","series-title":"JAMA Neurol","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaneurol.2014.367","article-title":"Blood biomarkers for brain injury in concussed professional ice hockey players","volume":"71","author":"Shahim P","year":"2014","unstructured":"Shahim P, Tegner Y, Wilson DH,  Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014;71(6):684\u2013692.2462703610.1001\/jamaneurol.2014.367"},{"issue":"5","key":"b5","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1017\/cjn.2019.61","article-title":"Detection of S-100\u03b2 protein in plasma and urine after a mild traumatic brain injury","volume":"46","author":"Le Sage N","year":"2019","unstructured":"Le Sage N, Tardif PA, Frenette J,  Detection of S-100\u03b2 protein in plasma and urine after a mild traumatic brain injury. Can J Neurol Sci. 2019;46(5):599\u2013602.10.1017\/cjn.2019.61"},{"issue":"pt 3","key":"b6","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2015.05.004","article-title":"Current status of fluid biomarkers in mild traumatic brain injury","volume":"275","author":"Kulbe JR","year":"2016","unstructured":"Kulbe JR, Geddes JW. Current status of fluid biomarkers in mild traumatic brain injury. Exp Neurol. 2016;275(pt 3):334\u2013352.2598188910.1016\/j.expneurol.2015.05.004"},{"issue":"10","key":"b7","series-title":"Nat Rev Neurol","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneurol.2016.127","article-title":"Fluid biomarkers for mild traumatic brain injury and related conditions","volume":"12","author":"Zetterberg H","year":"2016","unstructured":"Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016;12(10):563\u2013574.2763290310.1038\/nrneurol.2016.127"},{"issue":"3","key":"b8","series-title":"Clin Chem","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/clinchem\/46.3.319","article-title":"Plasma DNA as a prognostic marker in trauma patients","volume":"46","author":"Lo YMD","year":"2000","unstructured":"Lo YMD, Rainer TH, Chan LYS,  Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000;46(3):319\u2013323.1070251710.1093\/clinchem\/46.3.319"},{"issue":"20","key":"b9","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1089\/neu.2019.6375","article-title":"A Serum protein biomarker panel improves outcome prediction in human traumatic brain injury","volume":"36","author":"Thelin E","year":"2019","unstructured":"Thelin E, Al Nimer F, Frostell A,  A Serum protein biomarker panel improves outcome prediction in human traumatic brain injury. J Neurotrauma. 2019;36(20):2850\u20132862.3107222510.1089\/neu.2019.6375"},{"issue":"7","key":"b10","series-title":"Mol Neurobiol","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1007\/s12035-017-0821-y","article-title":"Protein biomarkers and neuroproteomics characterization of microvesicles\/exosomes from human cerebrospinal fluid following traumatic brain injury","volume":"55","author":"Manek R","year":"2018","unstructured":"Manek R, Moghieb A, Yang Z,  Protein biomarkers and neuroproteomics characterization of microvesicles\/exosomes from human cerebrospinal fluid following traumatic brain injury. Mol Neurobiol. 2018;55(7):6112\u20136128.2918849510.1007\/s12035-017-0821-y"},{"issue":"3","key":"b11","series-title":"J Neurosurg Anesthesiol","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/ANA.0b013e31821b536a","article-title":"Cell-free DNA\u2014a marker to predict ischemic brain damage in a rat stroke experimental model","volume":"23","author":"Boyko M","year":"2011","unstructured":"Boyko M, Ohayon S, Goldsmith T,  Cell-free DNA\u2014a marker to predict ischemic brain damage in a rat stroke experimental model. J Neurosurg Anesthesiol. 2011;23(3):222\u2013228.10.1097\/ANA.0b013e31821b536a"},{"issue":"12","key":"b12","series-title":"Medicine (Baltimore)","doi-asserted-by":"publisher","first-page":"e14863","DOI":"10.1097\/MD.0000000000014863","article-title":"Circulating cell-free DNA as a potential marker in smoke inhalation injury","volume":"98","author":"Hayun Y","year":"2019","unstructured":"Hayun Y, Shoham Y, Krieger Y,  Circulating cell-free DNA as a potential marker in smoke inhalation injury. Medicine (Baltimore).2019;98(12):e14863.10.1097\/MD.000000000001486330896631"},{"issue":"pt 6","key":"b13","series-title":"Ann Clin Biochem","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1258\/acb.2009.009002","article-title":"A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids","volume":"46","author":"Goldshtein H","year":"2009","unstructured":"Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem. 2009;46(pt 6):488\u2013494.1972950310.1258\/acb.2009.009002"},{"issue":"11","key":"b14","series-title":"Expert Rev Mol Diagn","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14737159.2018.1535904","article-title":"Prognostic utility of circulating nucleic acids in acute brain injuries","volume":"18","author":"Regner A","year":"2018","unstructured":"Regner A, da Silva Meirelles L, Ikuta N,  Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev Mol Diagn. 2018;18(11):925\u2013938.3030778610.1080\/14737159.2018.1535904"},{"issue":"2","key":"b15","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/neu.2011.1938","article-title":"Cell-free DNA as a marker for prediction of brain damage in traumatic brain injury in rats","volume":"29","author":"Ohayon S","year":"2012","unstructured":"Ohayon S, Boyko M, Saad A,  Cell-free DNA as a marker for prediction of brain damage in traumatic brain injury in rats. J Neurotrauma. 2012;29(2):261\u2013267.2214992710.1089\/neu.2011.1938"},{"issue":"1","key":"b16","series-title":"Scand J Trauma Resusc Emerg Med","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1757-7241-22-21","article-title":"The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries","volume":"22","author":"Shaked G","year":"2014","unstructured":"Shaked G, Douvdevani A, Yair S,  The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries. Scand J Trauma Resusc Emerg Med. 2014;22(1):21.2464183310.1186\/1757-7241-22-21"},{"issue":"12","key":"b17","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.294.12.1519","article-title":"External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury","volume":"294","author":"Smits M","year":"2005","unstructured":"Smits M, Dippel DWJ, de Haan GG,  External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA. 2005;294(12):1519\u20131525.1618936510.1001\/jama.294.12.1519"},{"key":"b18","series-title":"Psychological Assessments Resources;","article-title":"Color Trails Test: Professional Manual","author":"D\u2019Elia LF","year":"1996","unstructured":"D\u2019Elia LF, Satz P, Uchiyama CL, White T. Color Trails Test: Professional Manual. Psychological Assessments Resources; 1996."},{"issue":"2","key":"b19","series-title":"Arch Clin Neuropsychol","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/arclin\/8.2.123","article-title":"Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study","volume":"8","author":"Maj M","year":"1993","unstructured":"Maj M, D\u2019Elia L, Satz P,  Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993;8(2):123\u2013135.1458967010.1093\/arclin\/8.2.123"},{"issue":"1","key":"b20","series-title":"J Trauma","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00005373-199901000-00027","article-title":"Assessment of executive function in patients with mild traumatic brain injury","volume":"46","author":"Brooks J","year":"1999","unstructured":"Brooks J, Fos LA, Greve KW, Hammond JS. Assessment of executive function in patients with mild traumatic brain injury. J Trauma. 1999;46(1):159\u2013163.993270010.1097\/00005373-199901000-00027"},{"issue":"6","key":"b21","series-title":"Clin Transl Med","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1002\/ctm2.197","article-title":"Diagnosing mild traumatic brain injury using saliva RNA compared to cognitive and balance testing","volume":"10","author":"Hicks SD","year":"2020","unstructured":"Hicks SD, Onks C, Kim RY,  Diagnosing mild traumatic brain injury using saliva RNA compared to cognitive and balance testing. Clin Transl Med. 2020;10(6):e197.3313534410.1002\/ctm2.197"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/6\/article-p1660.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/6\/article-p1660.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/6\/article-p1660.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:07:15Z","timestamp":1795223235000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/6\/article-p1660.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":21,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2021.5.jns21501","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}